HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials.

AuthorsR H Begent, K A Chester, T Connors, D Crowther, B Fox, E Griffiths, T A Hince, J A Ledermann, J G McVie, P Minor
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 29A Issue 13 Pg. 1907-10 ( 1993) ISSN: 0959-8049 [Print] England
PMID8260253 (Publication Type: Guideline, Journal Article, Practice Guideline)
Chemical References
  • Antineoplastic Agents
  • DNA, Recombinant
  • Recombinant Proteins
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Clinical Trials, Phase I as Topic
  • Consumer Product Safety
  • DNA, Recombinant
  • Drug Labeling
  • Humans
  • Recombinant Proteins (isolation & purification, therapeutic use)
  • Recombination, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: